As countries progress towards malaria elimination, the need to detect submicroscopic infections is becoming increasingly important, as reservoirs of infected persons may result in transmission even without the manifestation of clinical illness ( [@B20] ). Since the 1990s, important progress has been made in the molecular identification and characterisation of Plasmodium parasites. Polymerase chain reaction (PCR)-based diagnostic methods targeting the small subunit rRNA (18SSU rRNA) gene have had great impacts because they allow for the specific detection of the four major human *Plasmodium* species at densities several times lower than the limit of optical microscopy (OM) detection, the mainstay for malaria diagnosis ( [@B28] , [@B16] , [@B33] ). The next methodological improvement was the introduction of the adapted kinetic PCR, also referred to as real-time (RT) quantitative PCR, which decreased the time spent on conventional PCR protocols and the risks of contamination, as well as allowed for large-scale analyses ( [@B11] , [@B32] , [@B7] ). Although the application of PCR-based methods for the routine diagnosis of malaria remains a target difficult to achieve ( [@B19] ), this technology has greatly impacted the fields of malaria epidemiology, chemotherapy and vaccine development.

While the specificity of the PCR results is guaranteed by the nature of the target and the primers and/or probes, the sensitivity can be highly variable, depending on which protocols are used and the population that is undergoing malaria diagnosis ( [@B12] , [@B3] ) . Considering that the prevalence of malaria has been significantly reduced in some areas over the past decade, a critical issue is the accurate detection of asymptomatic individuals with microparasitaemic infections ( [@B31] ). This challenge could adversely impact the study of malaria control if it remains unsolved. Unfortunately, the validity of the PCR-based detection methods has not been adequately assessed for asymptomatic or microparasitaemic individuals . Therefore, to investigate how reproducible the results of the PCR assays are in detecting submicroscopic malaria infection, we evaluated the performance of two well-established and distinct 18SSU rRNA PCR protocols - nested-PCR ( [@B28] ) and RT- PCR ( [@B18] ) - against a panel of field samples from long-term residents of a rural malaria-endemic area in the Amazon where asymptomatic malaria infections often occur ( [@B17] ). Because comparing the two traditional PCR protocols was not the focus of the current paper, the methodological approach includes the use of nested-PCRas a gold standard, as suggested by others ( [@B19] ) and RT-PCR as an additional protocol to strengthen the results.

SUBJECTS, MATERIALS AND METHODS
===============================

*Panel of samples -* In this study, we included 34 samples from long-term residents of an endemic Amazon rural community, Colniza, state of Mato Grosso (MT); subclinical malaria infections were characterised in this area during a detailed descriptive epidemiology study carried out between 2003-2009 ( [@B17] ). In that study, the parasitological and epidemiological data from seven consecutive years identified a small community, herein referred to as Colniza, where 55.91% of all malaria cases were subclinical. Consequently, malaria infection could not be excluded *a priori* in the individuals exposed to malaria in Colniza. Colniza is located inside the Amazon forest in the northwest of MT, roughly 1,200 km from the capital Cuiabá; Colniza can be accessed by two paved roads, which connect MT to the states of Amazonas (BR-174) and Rondônia (MT-206). The economic activities of this municipality are based mainly on wood extraction and livestock. Malaria is transmitted year-round with an Annual Parasitological Index (API) of 98.5 cases per 1,000 inhabitants ( [@B17] ). Samples were collected in this area in 2008 during a survey of asymptomatic patients in the area. The following eligibility criteria were included: (i) a minimum age of 15 years, (ii) the absence of pregnancy, (iii) a lifetime exposure to malaria in the Colniza area, (iv) no self-reported symptoms suggestive of malaria, such as fever, myalgia, chills or headache and (v) negative blood parasites by direct examination of Giemsa-stained thick blood smears. Although all samples were negative by OM, 14 out of 34 (41%) samples were positive according to a malaria-specific nested-PCR ( [@B28] ), which was performed later in our laboratory. Consequently, all of the Colniza samples were initially considered individuals who might have submicroscopic parasitaemia and may therefore be potential malaria carriers. As a positive control, we included 52 field samples from patients who sought care at a regional reference malaria laboratory (Julio Muller University Hospital, Federal University of Mato Grosso, Cuiabá) and whose thick blood smears were positive for malaria. Based on the OM results, the parasite densities of the positive controls ranged from high (\> 1,000 parasites µL/blood, n = 16), to medium (1,000-301 µL/blood, n = 16) and low parasitaemia (100-300 parasites µL/blood, n = 20). As a negative control, 20 blood samples from volunteers living outside of the endemic area were included; these volunteers had never been infected or exposed to the malaria parasites.

*Ethics* - The ethical and methodological aspects of this study were approved by the Ethical Committee of Research on Human beings from the René Rachou Research Centre/Oswaldo Cruz Foundation (reports 07/2006 and 01/2009), according to the Resolution of the Brazilian Council on Health 196/96.

*Blood examination* - The Giemsa-stained thick blood smear technique was used for malaria diagnosis in all of the samples in the present study; during this examination, long-term experienced microscopists were in charge of examining the equivalent of 0.2 µL of blood (roughly 100 microscopy fields). For quality assurance, each slide was examined by two microscopists who had over 10 years of experience in reading malaria slides; their proficiency was periodically evaluated by local/regional quality assurance programs of the Brazilian Ministry of Health (MS). Parasite density was estimated as the number of parasites per microlitre of blood, in accordance with the standards of the MS.

*Whole blood samples and preparation of the DNA template* - At the time of the thick blood smear preparation, 5 mL of blood was drawn into sterile tubes containing ethylenediamine tetraacetic acid and aliquots (1 mL) of the whole blood were subsequently used to purify the templates for the PCR assays. Blood was stored at -70ºC until it was processed. Genomic DNA was extracted using a Qiagen genomic DNA purification kit (Puregene ^®^ ) (Gentra Systems, Minneapolis, MN, USA), according to the manufacturers' recommendations. The DNA was eluted in a 330-µL volume (≅100 ng of DNA /µL) and stored at -20ºC until it was used.

*Nested-PCR -* Samples were amplified using a nested-PCR protocol adapted from the original protocol described by [@B28] ; the same primers described in the original study were used in this study. Briefly, all PCR reactions were performed in 20 µL volumes containing 250 µM each oligonucleotide primer, 10 µL of Master Mix (Promega) (0.3 units of Taq Polymerase, 200 µM each deoxyribonucleotide triphosphates and 1.5 mM MgCl ~2~ ) and 2 μL of DNA (≅6 μL of whole blood). The PCR assays were performed using an automatic thermocycler (PTC-100 ^TM^ v.7.0) (MJ Research Inc, USA) and the following cycling parameters were used: an initial denaturation at 95ºC for 5 min followed by 24 cycles of annealing at 58ºC for 2 min, extension at 72ºC for 2 min and denaturation at 94ºC for 1 min followed by a final annealing incubation at 58ºC for 2 min and extension at 72ºC for 2 min. The temperature was then reduced to 4ºC until the samples were taken. The cycling parameters for the second round of PCR were the same as the first reaction, but instead 30 cycles of amplification were used. The amplified products were detected by ethidium bromide staining following agarose 2% gel electrophoresis (Invitrogen) and the species-specific fragment sizes were 205 bp for *Plasmodium falciparum* , 120 bp for *Plasmodium vivax* and 144 bp for *Plasmodium malariae* . Because human DNA represents the majority of the DNA in the samples, a gene present in the ABO human system was amplified in the panel of samples to determine the quality control of the DNA extraction, as previously described ( [@B23] ).

*RT-PCR -* Identification of the malaria parasite species was performed by RT-PCR amplification of the 18SSU rRNA gene, as previously described ( [@B18] ); based on this protocol, a consensus pair of primers was used to amplify a species-specific region of the multicopy 18SSU rRNA gene. Briefly, each 20 µL reaction mix contained 2 μL of genomic DNA (≅6 μL of whole blood), 10 µL of Sybr ^®^ Green PCR master mix (Applied Biosystems), 2.5 mM MgSO ~4~ (final concentration) and 0.5 μM of each primer (BioSynthesis). The PCR conditions consisted of an initial denaturation at 95ºC for 10 min followed by 40 cycles of 90ºC for 30 sec and 60ºC for 30 sec; fluorescence acquisition was performed at the end of each extension step. After amplification, the melting curves were observed from the dissociation curves and those melting curve analyses, which were based on nucleotide variations within the amplicons, provided a basis for the accurate differentiation of the three plasmodia: *P. falciparum, P. vivax* and *P. malariae* . The amplification and fluorescence detection were performed using the ABI PRISM ^®^ 7000 Sequence Detection System (Applied Biosystems). The range of melting temperatures ( *T* ~*m*~ *)* for each *Plasmodium* was 74-76ºC for *P. vivax* , 71-73ºC for *P. falciparum* and 68-70ºC for *P. malariae* .

*Reproducibility of the PCR reactions* - Initially, each DNA sample from the individuals who might harbour submicroscopic parasitaemia (Colniza; potential malaria carriers) were submitted to three PCR reactions. We amplified the 18SSU rRNA gene using nested-PCR, which is widely regarded as the "gold standard" for the PCR detection of malaria parasites ( [@B19] ). Additionally, the samples were also submitted to a second PCR protocol (RT-PCR for the *Plasmodium* 18SSU rRNA gene). After this first round of PCR, the Colniza samples were considered positive or negative if all of the PCR results were consistent. For the discordant results, the samples were submitted to a second round of PCR, which included a re-amplification using the gold-standard nested-PCR protocol and two additional replicates of the RT-PCR method; this approach ensured that each discordant sample was retested at least three times by each PCR protocol. Afterwards, the discordant samples were classified as doubtful for malaria infection. For samples from patients with microscopically detectable parasitaemia (positive controls), a consensus result per protocol was based on the agreement between at least three PCR results.

*Statistical analysis -* A chi-squared analysis was performed to compare the nested and RT-PCR protocols and to compare the single vs. multiple reactions. The agreement between the different assays was evaluated using McNemar's chi-squared analysis and the kappa (κ) coefficient of agreement. A 5% level of difference was considered significant.

RESULTS
=======

*Performance of the nested-PCR and RT-PCR protocols against a panel of reference samples* - As an internal control, microscopically positive (n = 52) and negative (n = 20) control samples were evaluated using the nested and RT-PCR methods ( [Table I](#t01){ref-type="table"} ). Both PCR protocols were specific as no positive results were obtained from the blood samples of the 20 malaria naïve volunteers. Regardless of the PCR protocol, PCR accurately identified 98-100% of the microscopy-positive samples; concerning the reproducibility of the PCR amplification, no significant differences were observed after retesting all 72 control samples (3-5 replicates per protocol). Additionally, for the *Plasmodium* species-specific identification, the results of both PCR protocols were highly reproducible and, in general, equivalent to those obtained by OM ( [Table II](#t02){ref-type="table"} ). As expected, the PCR protocols detected a number of mixed infections ( *P. vivax* plus *P. falciparum* ) that could not be detected by microscopy ( [Table II](#t02){ref-type="table"} ). The reproducibility of the PCR methods was confirmed using κ statistics, which demonstrated that no difference was observed between the single and multiple PCR reactions or between the nested and RT-PCR protocols (κ-values of 0.70-0.91; McNemar test, p \> 0.05).

TABLE IPerformance of polymerase chain reaction (PCR) protocols evaluated against a panel of reference samples with single or multiple assays realised per PCR protocolSamplesParasites/µL(n) ^*a*^Nested-PCR positive n (%)RT-PCR positive n (%)Single ^*b*^MultipleSingleMultiplePositive\> 100 (52)51 (98)52 (100)51 (98)51 (98)Negative0 (20)0 (0)0 (0)0 (0)0 (0)*a* : parasitaemia as detected by optical microscopy; *b* : single, the result of the first PCR reaction, and multiple, the results of three concordant PCR reactions. There were no statistical differences between results from single vs. multiple PCR assays or from nested vs. real-time (RT)-PCR for single vs. multiple reactions (p \> 0.05).

TABLE IIPolymerase chain reaction (PCR) performance for the detection of *Plasmodium falciparum* and/or *Plasmodium vivax* at microscopically positive samples*Plasmodium* speciesOM ^*a*^Positive samples n (%)Nested-PCRRT-PCRSingle ^*b*^MultipleSingleMultiple*P. vivax*41 (79)40 (77)40 (77)40 (77)40 (77)*P. falciparum*11 (21)9 (17)10 (19)10 (19)10 (19)Mixed02 (4)2 (4)1 (2)1 (2)Negative01 (2)0 (0)1 (2)1 (2)*a* : optical microscopy (OM), which included 52 samples positive at parasite density \> 100 parasites per µL of blood; *b* : nested-PCR and real-time (RT)-PCR were carried-out as described in Subjects, Materials and Methods; single, the first PCR reaction, and multiple, the results of three concordant PCR reactions.

*Evaluation of PCR performance for detecting submicroscopic malaria infections* - Thirty-four samples from long-term residents of a rural Amazon community with frequent subclinical malaria infections (potential malaria carriers) were assayed using both PCR-based protocols. At the time of the blood collection, all of these individuals had a negative malaria thick blood smear, but 14 out of 34 (41%) individuals were positive for malaria according to the nested-PCR assay, which was performed in parallel. To evaluate the reproducibility of the DNA amplification by the PCR-based protocols, each sample was submitted to three additional PCR reactions (nested and RT-PCR); to reach a molecular consensus, the discordant samples were re-amplified by additional PCR assays ( [Table III](#t03){ref-type="table"} ). Molecular consensus confirmed the submicroscopic malaria infection in seven (21%) individuals and excluded this possibility in 14 samples (41%). In 13 (38%) samples, the PCR replicates led to alternating positive or negative results and these discrepancies probably reflect the limitations of the molecular methods at low levels of parasitaemia. Regarding the identification of the *Plasmodium* species, only two samples (917 and 930) were discordant; nested-PCR identified these samples as mixed infections, however these results were not confirmed by RT-PCR. On the other hand, no positive results were obtained from the blood samples from five malaria naïve volunteers (data not shown).

TABLE IIIReproducibility of polymerase chain reaction (PCR)-based protocols among 34 long-term residents of an Amazon rural community who might harbour submicroscopic parasitaemia (potential malaria carriers) ^*a*^CodeNested-PCRRT-PCRConsensus result n (%)FirstSecondThirdFourth FirstSecondThird903NEGNEGNEGNDNEGNDND-906NEGNEGNEGNDNEGNDND-907NEGNEGNEGNDNEGNDND-909NEGNEGNEGNDNEGNDND-911NEGNEGNEGNDNEGNDND-912NEGNEGNEGNDNEGNDND-913NEGNEGNEGNDNEGNDNDNegative, 14 (41)918NEGNEGNEGNDNEGNDND-920NEGNEGNEGNDNEGNDND-922NEGNEGNEGNDNEGNDND-923NEGNEGNEGNDNEGNDND-934NEGNEGNEGNDNEGNDND-935NEGNEGNEGNDNEGNDND-936NEGNEGNEGNDNEGNDND-902FVFVFVNDFVNDND-904VVVNDVNDND-916VVVNDVNDND-921VVVNDVNDNDPositive, 7 (21)924VVVNDVNDND-925VVVNDVNDND-929VVVNDVNDND-901MNEGNEGNEGNEGNEGNEG-908VNEGNEGNEGVNEGNEG-915NEGNEGVNEGVVV-928NEGNEGVNEGNEGNEGNEG-919NEGNEGFFNEGNEGNEG-905FNEGNEGFFNEGNEGDoubtful, 13 (38)910NEGVNEGVVVV-917NEGFVFVFVVVV-930FVNEGFVNEGVVV-926VNEGNEGVNEGNEGNEG-927NEGVVVNEGNEGNEG-932VVVNDNEGNEGV-933FNEGNEGNEGNEGNEGF-*a* : initially, each sample was submitted to the first round of PCR \[3 nested-PCR (gold-standard) and 1 real-time (RT)-PCR\]. Samples with discordant results were resubmitted to a second round of PCR (1 nested-PCR and 2 RT-PCR). This approach allowed that discordant samples were classified as doubtful after being tested at least in triplicate by each PCR protocol. Results were indicated as positive by *Plasmodium vivax* (V), *Plasmodium falciparum* (F), *Plasmodium malariae* (M) and mixed infection by *P. falciparum* and *P. vivax* (FV). ND: not done; NEG: PCR negative for *Plasmodium* infection.

Of importance, the limitation of PCR amplification at low levels of parasitaemia was restricted to DNA from field samples because titrations of DNA templates obtained from the *Plasmodium* reference isolates or species-specific plasmid constructions could be detected at concentrations of less than three parasites/µL of blood. [Figs 1](#f01){ref-type="fig"} , [2](#f02){ref-type="fig"} illustrate the end-point DNA titrations of the RT-PCR method, in which the DNA templates were obtained from cultured *P. falciparum* or from an artificially mixed infection obtained from highly-parasitaemic individuals infected with *P. falciparum* and *P. vivax* (≅10,000 parasites/µL of blood). Similar results were obtained using the nested-PCR protocol (data not shown).

Fig. 1: real-time polymerase chain reaction melting curve analysis obtained from DNA template dilutions from *Plasmodium falciparum* continuous erythrocyte culture. The *P. falciparum* parasite (BHz 26/86), a chloroquine-resistant isolate ( [@B6] ), was maintained in culture by the candle jar method ( [@B14] ), with cultures maintained synchronised as described ( [@B13] ). Serial dilutions of samples included were 3,000, 300, 30, 3, 0.3 and 0 parasite/µL of blood. The graph was generated by using the ABI PRISM ^®^ 7000 Sequence Detection System (Applied Biosystems).

Fig. 2: real-time polymerase chain reaction melting curve analysis obtained from DNA template dilutions from and artificial *Plasmodium falciparum* and *Plasmodium vivax* infection. The graph was generated by using the ABI PRISM ^®^ 7000 Sequence Detection System (Applied Biosystems). Serial dilutions of samples included were 3,000, 300, 30, 3, 0.3 and 0 parasite/µL of blood.

DISCUSSION
==========

As part of the international effort to reduce the global incidence of malaria, it has been proposed that the treatment of asymptomatic carriers should be an essential tool for breaking the cycle of infection in some transmission settings ( [@B22] ). However, improved diagnostic tests are needed to reach this goal in order to accurately detect submicroscopic malaria infections. Although it has been claimed that PCR-based protocols are capable of detecting very low levels of parasitaemia, the reproducibility of these methods in malaria field samples has been largely underestimated. Here, the main goal was to analyse the reproducibility of the PCR-based protocols in detecting submicroscopic malaria infections. Therefore, field samples, not standard DNA templates, were used in this analysis because some, if not all, of the field samples may contain inhibitors that are not present in the standard DNA samples ( [@B1] , [@B10] ). In this context, we selected the Colniza area due to the high frequency of subclinical malaria, which made it feasible to identify submicroscopic malaria infections. Following this protocol, we demonstrated that the traditional PCR amplification protocols might not be able to accurately and reproducibly identify potential submicroscopic malaria carriers. In fact, the PCR results were inconsistent in 13 out of the 34 (\~40%) individuals, even after seven replicates of each DNA template (4 nested-PCR replicates and 3 RT-PCR replicates) were performed. These results were quite different from those obtained from the replicate samples of the microscopic positive patients, which could be confirmed with a high degree of reproducibility using both PCR-based protocols.

As in the endemic areas where the cost of diagnostic tests becomes a limiting factor, we decided to use the simplest and most economical format of RT-PCR in this study, which relied on the detection of the fluorescent reporter SYBR Green I. While the sensitivity of SYBR Green is similar to other RT chemistries, the specificity of the reporter may be misleading in some few cases due to variations in the amount of template ( [@B24] ). In the present study, it was possible to rule out this potential limitation of the SYBR-based protocols because RT-PCR was 100% specific, with no positive results from the negative controls (naïve volunteers). Additionally, similar results were obtained with both the nested-PCR and RT-PCR methods, suggesting the low variability between these two assay platforms based on the 18SSU rRNA gene. It is important to emphasise that the reproducibility of the SYBR Green protocols could be due to variations in the *T* ~*m*~ that impact the melting curves, for example. However, this does not seem to be the case here, as the optimisation of the PCR reactions resulted in a very small variation in the *Tm* values. Additionally, based on our positive panel of samples, which included a wide-range of parasitaemia, the SYBR Green protocol was reproducible after multiple repetitions. Finally, the low reproducibility for detecting submicroscopic parasitaemia was not exclusive to the SYBR green protocol, but was also observed with the gold-standard nested-PCR. In conclusion, we agree with others that protocols based on SYBR Green are more cost efficient in endemic areas than the alternatives that use internal fluorogenic probes ( [@B21] ).

Concerning mixed-species infections, while the nested-PCR method identified five dual infections of *P. falciparum* and *P. vivax* , the RT method only identified two. Because the RT-PCR protocol used here was based on single consensus primers, this result suggests that the mixed infection was misidentified; however, this RT-PCR protocol has been used to amplify mixed-malaria infections ( [@B18] ). Because a comparison between the PCR protocols was not the focus of this paper, further studies will be required to properly address this question.

The results concerning the poor performance of the PCR methods for the identification of submicroscopic malaria infections corroborate previous observations of the irreproducibility of parasite detection in samples with very low levels of parasitaemia ( [@B27] ). This result means that any PCR template diluted past a certain threshold copy number will experience large variations in amplification. The absence of amplification at very low levels of parasitaemia was not related to the DNA extraction protocol because, as an internal control, a sequence of the ABO human genome was amplified in all of the tested samples. Although relevant, this internal control did not exhibit the specific amplification difficulties derived from field samples with low amounts of parasite DNA. This inherent limitation of PCR amplification, previously described as the Monte Carlo effect ( [@B15] ), has been widely underestimated ( [@B30] , [@B29] ). In fact, specific parasite PCR amplification at very low parasite densities may be hindered by several distinct factors, including the biological sample itself ( [@B8] ), the concentration of human genomic DNA ( [@B1] ), the scarcity of the template ( [@B10] , [@B26] ), variations in the amplification conditions ( [@B5] ) and the PCR reagents, even when using premade master mixes from the same manufacturer ( [@B4] ).

Regarding the scarcity of the template, it is clear that the likelihood of detecting parasites present at very low levels decreases as the volume of blood analysed decreases. Thus, for the detection of submicroscopic infections, it has been proposed that the DNA templates to be analysed by PCR should correspond to at least 5 μL of the whole blood ( [@B25] ). In the current paper, to avoid this potential limitation, both PCR protocols were performed with 2 μL of template, which corresponded to approximately 6 μL of the whole blood collected from the patient. Because the use of templates isolated from substantially higher volumes of blood might encounter difficulties due to the high quantities of human DNA, blood filtration methods for the removal of leukocytes have been proposed to increase the PCR sensitivity during malaria vaccine clinical trials ( [@B1] , [@B2] ). After performing a multistep protocol, during which 5 mL of blood was filtered to remove the leukocytes, [@B1] established a PCR cut-off point of 20 parasites/mL to follow the vaccinated volunteers in the Phase II trials. Taken together, these results mean that the most commonly used PCR methods might not accurately detect subclinical malaria infections. These findings could be particularly relevant when studying malaria in low transmission settings, where a negative PCR result may indicate that the individual is truly negative or may be a consequence of insufficient sensitivity of the PCR tests. At this time, it is not possible to differentiate between these two possible outcomes as the validity of PCR has not been adequately assessed for asymptomatic or microparasitaemic individuals ( [@B31] ).

Although the results described here show a clear inconsistency of the PCR results in sub-patent malaria infections, the current results have limitations. The absence of similar studies performed with field samples makes it hard to compare our results with other researchers; in fact, the consistency of the PCR results in the submicroscopic carriers has never been properly assessed, especially in field settings where sample collection and storage may not be optimal ( [@B31] ). Additionally, the amplification of scarce DNA templates by any PCR-based protocol requires a very high standard of laboratory practice. Because we have well-trained and qualified personnel and we followed the requirements of the International Organization for Standardization/ International Electrotechnical Commission 17025, it was possible to minimise technical problems, such as those related to the adequate manipulation of the devices used in the PCR assays. Consequently, at present, the application of PCR-based methods is restricted to well-equipped laboratories with specially trained technicians. To develop new strategies to manage the parasite-negative individuals, PCR capacity building programs are underway in several African countries with the help of the Malaria Clinical Trials Alliance ( [@B19] ). Unfortunately, an initiative of this magnitude has not yet been initiated in Latin America, where *P. vivax* is the predominant species.

It is critical to achieve a sufficient sample size when studying areas with sub-patent malaria infections in order to have an adequately powered study. In this context, the size of our sample set could not be increased in the Colniza area; the geographical access and political conflicts, which often affect the gold-mining areas of the Brazilian Amazon, hampered the continuation of our study there. Accordingly, the malERA initiative stated that sufficiently powered studies are difficult to implement in settings with low malaria prevalence and this challenge could adversely impact malaria control ( [@B19] ). Regrettably, at the moment, this question remains unsolved.

In conclusion, our data show that conventional PCR protocols based on the 18SSU rRNA plasmodial gene do not allow for the accurate detection of submicroscopic malaria infections. Consequently, PCR results require careful interpretation when the population of interest includes microparasitaemic individuals. Currently, no PCR protocol is able to bypass the lack of PCR reproducibility at low levels of parasitaemia. Although some new protocols have promise, such as loop-attenuated isothermal amplification, these protocols have not yet been adequately tested in community-based studies or in the detection of low-density parasitaemia ( [@B9] ). Thus, studies are required to decrease the current limit of detection in the PCR assays in low-transmission settings. Furthermore, we agree with researchers that these protocols should be validated as a useful tool for the accurate detection of submicroscopic malaria infection, through comparative multicentre studies and this step is essential before these protocols are put into practice ( [@B25] ).
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